CN101684083A
|
|
Guanidinoalkanoylamino substituted tetracycline derivatives
|
CN101486688A
|
|
DPP-IV inhibitor with sulfonyl amine acyl alkyl piperazine structure
|
CN101372490A
|
|
Penem derivative containing sulfhydryl nitrogen heterocyclic ring and vinyl nitrogen heterocyclic ring
|
CN101343272A
|
|
Carbpenem compound containing cyclohexane
|
CN101525336A
|
|
Carbapenem compound containing substituted formohydrazide group
|
CN101328177A
|
|
Nitrogen heterocyclic ring vinyl substituted sulfhydryl heterocycle carbpenem compounds
|
CN101210022A
|
|
Cephalosporin
|
CN101190922A
|
|
Cephalosporin derivative
|
CN101153045A
|
|
Novel cephalosporin compounds
|
CN101143870A
|
|
Novel cephalosporin derivative
|
CN101002843A
|
|
Medicine composition used for treating cardiovascular and cerebrovascular diseases
|
CN101190253A
|
|
Medicinal composition containing mongolian snakegourd and notoginseng
|
CN101190254A
|
|
Medicinal composition containing kudzu root or its extract and mongolian snakegourd or its extract
|
CN1969957A
|
|
Pharmaceutical composition comprising flavescent sophora root, magnolia vine fruit and astragalus root
|
CN101176770A
|
|
Pharmaceutical composition of folium ginkgo and cattail pollen
|
CN101161268A
|
|
Pharmaceutical composition of red sage root and cattail pollen
|
CN1939417A
|
|
Medicinal composition of douricine, tinosporae or its extract
|
CN101138588A
|
|
Pharmaceutical composition for treating gland hyperplasia and method of preparing the same
|
CN101120972A
|
|
Traditional Chinese medicine for treating angina pectoris
|
CN101116683A
|
|
Medicine for treating arthritis
|